부산대학교 도서관

Spencer, Kristen; Pappas, Leontios; Baiev, Islam; Maurer, Jordan; Bocobo, Andrea Grace; Zhang, Karen; Jain, Apurva; Armas, Anaemy Danner De; Reyes, Stephanie; Le, Tri Minh; Rahma, Osama E; Stanton, Jennifer; DeLeon, Thomas T; Roth, Marc; Peters, Mary Linton B; Zhu, Andrew X; Lennerz, Jochen K; Iafrate, A John; Boyhen, Kylie; VanCott, Christine

JNCI: Journal of the National Cancer Institute. Jul2023, Vol. 115 Issue 7, p870-880. 11p.

Tyan, Kevin; Abu-Shawer, Osama; Baginska, Joanna; Severgnini, Mariano; Manos, Michael; Vaitkevicius, Henrikas; Grover, Shilpa; Hodi, F Stephen; Rahma, Osama E

Immunotherapy (1750743X); Aug2022, Vol. 14 Issue 11, p843-850, 8p

Reid P; Division of Rheumatology, Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA.; Sandigursky S; Division of Rheumatology, Department of Medicine, NYU Langone Health, New York, NY, USA.; Song J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lopez-Olivo MA; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Safa H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cytryn S; Division of Internal Medicine, Department of Medicine, NYU Langone Health, New York, TX, USA.; Efuni E; Division of Internal Medicine, Department of Medicine, NYU Langone Health, New York, TX, USA.; Buni M; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pavlick A; Medical Oncology, Weill Cornell Medical Center, New York, NY, USA.; Krogsgaard M; Perlmutter Cancer Center, Department of Pathology, NYU Langone Health, New York, NY, USA.; Abu-Shawer O; Department of Internal Medicine, Harvard Medical School, Boston, MA, USA.; Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.; Altan M; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Weber JS; Perlmutter Cancer Center, Department of Medicine, NYU Langone Health, New York, NY, USA.; Rahma OE; Department of Internal Medicine, Harvard Medical School, Boston, MA, USA.; Department of Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Suarez-Almazor ME; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Abdel-Wahab N; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Rheumatology and Rehabilitation, Faculty of Medicine, Assiut University Hospitals, Assiut, Egypt.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

Huffman BM; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Rahma OE; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Tyan K; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Li YY; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Giobbie-Hurder A; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Schlechter BL; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Bockorny B; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Manos MP; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cherniack AD; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Baginska J; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Mariño-Enríquez A; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Kao KZ; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Maloney AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ferro A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Kelland S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ng K; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Singh H; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Welsh EL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pfaff KL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Giannakis M; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Rodig SJ; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; ImmunoProfile, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts.; Hodi FS; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cleary JM; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Oberstein PE; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Kawaler EA; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York.; Cardot-Ruffino V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Rahma OE; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Beri N; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Enzinger P; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Huffman BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Perez KJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Schlechter BL; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Surana R; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Wang SJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Remland J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Bollenrucher N; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Chang E; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ali LR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Lenehan PJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Dolgalev I; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Werba G; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York.; Lima C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Keheler CE; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Sullivan KM; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Dougan M; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Hajdu C; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Pathology, NYU Langone Health, New York, New York.; Dajee M; Novartis Institute for Biomedical Research, Cambridge, Massachusetts.; Pelletier MR; Novartis Institute for Biomedical Research, Cambridge, Massachusetts.; Nazeer S; Novartis Pharmaceuticals, Cambridge, Massachusetts.; Squires M; Novartis Pharmaceuticals, Cambridge, Massachusetts.; Bar-Sagi D; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Nowak JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Simeone DM; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Till JE; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; McDaniel L; Personalis, Inc., Menlo Park, CA, USA.; Chang C; Indiana University School of Medicine, Indianapolis, IN, USA.; Long Q; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Pfeiffer SM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Lyman JP; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Padrón LJ; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Maurer DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Yu JX; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Gherardini PF; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Da Silva DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; LaVallee TM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Abbott C; Personalis, Inc., Menlo Park, CA, USA.; Chen RO; Personalis, Inc., Menlo Park, CA, USA.; Boyle SM; Personalis, Inc., Menlo Park, CA, USA.; Bhagwat N; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Cannas S; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Sagreiya H; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Li W; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Yee SS; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Abdalla A; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Wang Z; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Yin M; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Ballinger D; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Wissel P; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Eads J; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Karasic T; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Schneider C; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; O'Dwyer P; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Teitelbaum U; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Reiss KA; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Rahma OE; Dana-Farber Cancer Institute, Boston, MA, USA.; Fisher GA; Stanford University, Stanford, CA, USA.; Ko AH; University of California, San Francisco, San Francisco, CA, USA.; Wainberg ZA; University of California, Los Angeles, Los Angeles, CA, USA.; Wolff RA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; O'Hara MH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Vonderheide RH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Carpenter EL; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. erical@upenn.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Gupta, Shruti; Short, Samuel AP; Sise, Meghan E; Prosek, Jason M; Madhavan, Sethu M; Soler, Maria Jose; Ostermann, Marlies; Herrmann, Sandra M; Abudayyeh, Ala; Anand, Shuchi; Glezerman, Ilya; Motwani, Shveta S; Murakami, Naoka; Wanchoo, Rimda; Ortiz-Melo, David I; Rashidi, Arash; Sprangers, Ben; Aggarwal, Vikram; Malik, A Bilal; Loew, Sebastian; Carlos, Christopher A; Chang, Wei-Ting; Beckerman, Pazit; Mithani, Zain; Shah, Chintan V; Renaghan, Amanda D; De Seigneux, Sophie; Campedel, Luca; Kitchlu, Abhijat; Shin, Daniel Sanghoon; Rangarajan, Sunil; Deshpande, Priya; Coppock, Gaia; Eijgelsheim, Mark; Seethapathy, Harish; Lee, Meghan D; Strohbehn, Ian A; Owen, Dwight H; Husain, Marium; Garcia-Carro, Clara; Bermejo, Sheila; Lumlertgul, Nuttha; Seylanova, Nina; Flanders, Lucy; Isik, Busra; Mamlouk, Omar; Lin, Jamie S; Garcia, Pablo; Kaghazchi, Aydin; Khanin, Yuriy; Kansal, Sheru K; Wauters, Els; Chandra, Sunandana; Schmidt-Ott, Kai M; Hsu, Raymond K; Tio, Maria C; Mothi, Suraj Sarvode; Singh, Harkarandeep; Schrag, Deborah; Jhaveri, Kenar D; Reynolds, Kerry L; Cortazar, Frank B; Leaf, David E; Salem, Joe-Elie; Bagnis, Corinne Isnard; Rahma, Osama E; Mothi, Suraj S; Selamet, Umut; Chang, Weiting; Hirsch, Jamie S; Sakhiya, Vipulbhai; Stalbow, Daniel; Wu, Sylvia; Cennamo, Armando; Papa, Sophie; Rigg, Anne; Shaunak, Nisha; Kibbelaar, Zoe A; Benesova, Karolina

Journal for ImmunoTherapy of Cancer, vol 9, iss 10

Atieh J; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER) and Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St. S.W., Rochester, MN, USA.; Sack J; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Thomas R; Harvard Medical School, Boston, MA, USA.; Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.; Rahma OE; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA, USA.; Camilleri M; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER) and Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St. S.W., Rochester, MN, USA. camilleri.michael@mayo.edu.; Grover S; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.

Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 7902782 Publication Model: Print Cited Medium: Internet ISSN: 1573-2568 (Electronic) Linking ISSN: 01632116 NLM ISO Abbreviation: Dig Dis Sci Subsets: MEDLINE; PubMed not MEDLINE

Tyan K; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.; Center for Immuno-Oncology, Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.; Baginska J; Center for Immuno-Oncology, Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.; Brainard M; Center for Immuno-Oncology, Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.; Giobbie-Hurder A; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Severgnini M; Center for Immuno-Oncology, Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.; Manos M; Center for Immuno-Oncology, Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.; Haq R; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.; Center for Immuno-Oncology, Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.; Buchbinder EI; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.; Center for Immuno-Oncology, Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.; Ott PA; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.; Center for Immuno-Oncology, Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.; Hodi FS; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.; Center for Immuno-Oncology, Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.; Rahma OE; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA. Osamae_rahma@DFCI.harvard.edu.; Center for Immuno-Oncology, Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA. Osamae_rahma@DFCI.harvard.edu.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Atieh J; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER) and Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St. S.W., Rochester, MN, USA.; Sack J; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Thomas R; Harvard Medical School, Boston, MA, USA.; Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.; Rahma OE; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA, USA.; Camilleri M; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER) and Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St. S.W., Rochester, MN, USA. camilleri.michael@mayo.edu.; Grover S; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.

Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 7902782 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2568 (Electronic) Linking ISSN: 01632116 NLM ISO Abbreviation: Dig Dis Sci Subsets: MEDLINE

Monjazeb, Arta M; Giobbie-Hurder, Anita; Lako, Ana; Thrash, Emily M; Brennick, Ryan C; Kao, Katrina Z; Manuszak, Claire; Gentzler, Ryan D; Tesfaye, Anteneh; Jabbour, Salma K; Alese, Olatunji B; Rahma, Osama E; Cleary, James M; Sharon, Elad; Mamon, Harvey J; Cho, May; Streicher, Howard; Chen, Helen X; Ahmed, Mansoor M; Mariño-Enríquez, Adrian; Kim-Schulze, Seunghee; Gnjatic, Sacha; Maverakis, Emanual; Marusina, Alina I; Merleev, Alexander A; Severgnini, Mariano; Pfaff, Kathleen L; Lindsay, James; Weirather, Jason L; Ranasinghe, Srinika; Spektor, Alexander; Rodig, Scott J; Hodi, F Stephen; Schoenfeld, Jonathan D

Clinical Cancer Research, vol 27, iss 9

Gentzler, Ryan; Hall, Richard; Kunk, Paul R; Gaughan, Elizabeth; Dillon, Patrick; Slingluff, Craig L; Rahma, Osama E

Immunotherapy (1750743X); May2016, Vol. 8 Issue 5, p583-600, 18p

Ali LR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Lenehan PJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Cardot-Ruffino V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Katz MHG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bauer TW; Department of Surgery, University of Virginia Health System, Charlottesville, Virginia.; Nowak JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Patel A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Clancy TE; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Wang J; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Mancias JD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Reilley MJ; Division of Hematology and Oncology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia.; Stucky CH; Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix, Arizona.; Bekaii-Saab TS; Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix, Arizona.; Elias R; Hartford Healthcare Cancer Institute, Hartford, Connecticut.; Merchant N; Department of Surgery, University of Miami, Miami, Florida.; Slingluff CL Jr; Department of Surgery, University of Virginia Health System, Charlottesville, Virginia.; Rahma OE; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Hall WA; Froedtert and the Medical College of Wisconsin, Milwaukee, WI.; Li J; The University of Pittsburgh, Pittsburgh, PA.; You YN; University of Texas MD Anderson Cancer Center, Houston, TX.; Gollub MJ; Memorial Sloan Kettering Cancer Center, New York, NY.; Grajo JR; University of Florida, Gainesville, FL.; University of Florida Health Cancer Center, Gainesville, FL.; Rosen M; Imaging and Radiation Oncology Core (IROC) Group, and the University of Pennsylvania, Philadelphia, PA.; dePrisco G; Baylor Scott and White Health Baylor University Medical Center at Dallas, Dallas, TX.; Yothers G; The University of Pittsburgh, Pittsburgh, PA.; Dorth JA; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH.; Rahma OE; Dana-Farber/Harvard Cancer Institute, Boston, MA.; Russell MM; Department of Surgery, David Geffen School of Medicine at UCLA, and VA Greater Los Angeles Healthcare System, Los Angeles, CA.; Gross HM; Dayton Clinical Oncology Program, Dayton, OH.; Jacobs SA; NSABP Foundation, Pittsburgh, PA.; Faller BA; Missouri Baptist Medical Center/Heartland NCORP, St Louis, MO.; George S; Stephenson Cancer Center University of Oklahoma Health Sciences Center, Oklahoma City, OK.; Al Baghdadi T; Trinity Health Ann Arbor Hospital, Michigan Cancer Research Consortium (NCORP), Ann Arbor, MI.; Haddock MG; Mayo Clinic, Rochester, MN.; Valicenti R; University of California Davis Comprehensive Cancer Center/UC Davis School of Med/UC Davis Health, Sacramento, CA.; Hong TS; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; George TJ; University of Florida, Gainesville, FL.; University of Florida Health Cancer Center, Gainesville, FL.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Li M; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Sack JS; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Rahma OE; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hodi FS; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Zucker SD; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Grover S; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Grover S; Harvard Medical School, Boston, Massachusetts.; Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Dougan M; Harvard Medical School, Boston, Massachusetts.; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Tyan K; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Giobbie-Hurder A; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Blum SM; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute at MIT and Harvard, Cambridge, Massachusetts.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Ishizuka J; Departments of Medicine and Pathology, Yale University School of Medicine, New Haven, Connecticut.; Qazi T; Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Digestive Disease & Surgery Institute, Cleveland Clinic, Cleveland, Ohio.; Elias R; Hartford HealthCare Cancer Institute, Hartford, Connecticut.; Vora KB; Harvard Medical School, Boston, Massachusetts.; Ruan AB; Harvard Medical School, Boston, Massachusetts.; Martin-Doyle W; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Manos M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Eastman L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Davis M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Gargano M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Haq R; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Buchbinder EI; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Sullivan RJ; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Ott PA; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute at MIT and Harvard, Cambridge, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Hodi FS; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Rahma OE; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Kumar V; Department of Medical Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts, USA.; Shinagare AB; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Rennke HG; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Ghai S; Transplant Nephrology, Boston Medical Center, Boston, Massachusetts, USA.; Lorch JH; Department of Medical Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts, USA.; Ott PA; Department of Medical Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts, USA.; Rahma OE; Department of Medical Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Hallisey M; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Dennis J; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Gabriel EP; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Masciarelli A; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Chen J; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Abrecht C; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Brainard M; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Marcotte WM; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Dong H; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hathaway E; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Tarannum M; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.; Vergara JA; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.; Schork AN; Longwood Medical Area CyTOF Core, Dana-Farber Cancer Institute, Boston, Massachusetts.; Tyan K; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.; Tarantino G; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Liu D; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Romee R; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.; Rahma OE; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.; Severgnini M; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hodi FS; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Baginska J; Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: joanna_baginska@dfci.harvard.edu.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0376617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0307 (Electronic) Linking ISSN: 00236837 NLM ISO Abbreviation: Lab Invest Subsets: MEDLINE

Pappas L; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Baiev I; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Reyes S; Duke University School of Medicine, Durham, NC.; Bocobo AG; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.; Jain A; Division of Cancer Medicine, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Spencer K; Department of Medicine, NYU Langone Health Perlmutter Cancer Center, NYU School of Medicine, New York, NY.; Le TM; Department of Medicine, University of Virginia Comprehensive Cancer Center, Charlottesville, VA.; Rahma OE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Maurer J; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Stanton J; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Zhang K; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.; De Armas AD; Division of Cancer Medicine, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Deleon TT; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ.; Roth M; Department of Medical Oncology, St Luke's Cancer Institute, Kansas City, MO.; Peters MLB; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.; Zhu AX; Jiahui International Cancer Center, Jiahui Health, Shanghai, China.; I-MAB Biopharma, Shanghai, China.; Boyhen K; Yale University, New Haven, CT.; VanCott C; Department of Medicine, HCA Florida South Tampa Hospital, Tampa, FL.; Patel T; Department of Transplantation, Mayo Clinic, Jacksonville, FL.; Roberts LR; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.; Lindsey S; The Cholangiocarcinoma Foundation, Herriman, UT.; Horick N; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Lennerz JK; Center for Integrated Diagnostics, Department of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, MA.; Iafrate AJ; Center for Integrated Diagnostics, Department of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, MA.; Goff LW; Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN.; Mody K; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL.; Borad MJ; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ.; Shroff RT; University of Arizona Cancer Center, University of Arizona, Tucson, AZ.; Javle MM; Division of Cancer Medicine, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Kelley RK; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.; Goyal L; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medicine, Division of Oncology, Stanford Cancer Center, Palo Alto, CA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

George TJ; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, Florida.; Franke AJ; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, Florida.; Chakravarthy AB; Department of Radiation Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Das P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Dasari A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; El-Rayes BF; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.; Hong TS; Department of Radiation Oncology, Massachusetts General Hospital, Harvard, Boston, Massachusetts.; Kinsella TJ; Department of Radiation Oncology, Rhode Island Hospital-Brown University Alpert Medical School, Providence, Rhode Island.; Landry JC; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.; Lee JJ; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Monjazeb AM; Division of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California.; Jacobs SA; National Adjuvant Surgical and Bowel Project Foundation/NRG Oncology, Pittsburg, Pennsylvania.; Raben D; Department of Radiation Oncology, University of Colorado Denver School of Medicine, Aurora, Colorado.; Rahma OE; Center for Immuno-Oncology, Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Williams TM; Department of Radiation Oncology, The Ohio State University, Columbus, Ohio.; Wu C; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.; Coleman CN; Clinical Radiation Oncology Branch, Radiation Research Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Vikram B; Clinical Radiation Oncology Branch, Radiation Research Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Ahmed MM; Clinical Radiation Oncology Branch, Radiation Research Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE